Dr. Chandraker is an Associate Professor of Medicine at Harvard Medical School and has been the Medical Director of Kidney and Pancreas Transplantation at Brigham and Women’s Hospital since 2007. Previously he has also served as the Director of the Transplantation Research at Brigham and Women’s Hospital (2015-2020). He also served as the President of the American Society of Transplantation (2016-2017) and as Development Chair for the same organization (2018-2021).

As a clinician and researcher he has focused his efforts not only on translating research findings into therapeutics for unmet needs, but also on breaking down real and perceived barriers to development of novel therapies in the field of transplantation. He currently serves on the Executive Committee of the Transplant Therapeutic Consortium, a collaboration between the transplant community, including industry, academia, professional societies, and regulatory agencies with the goal of accelerating the medical product development process for transplantation.

He works in multiple areas of translational research including development of personalized regulatory T cell therapy for use in transplantation and is the founder of Anya Therapeutics. Dr. Chandraker received his medical degree from Glasgow University in Scotland and completed his clinical and research training in nephrology and transplant immunology at Brigham and Women’s Hospital.